Live Breaking News & Updates on European union eu clinical trial application

Stay updated with breaking news from European union eu clinical trial application. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in Lupus Nephritis

/PRNewswire/ -- Kyverna Therapeutics ("Kyverna"), a cell therapy company with the mission of engineering a new class of therapies for serious autoimmune...

Germany , Paul-ehrlich-institut , Peter-maag , National-institutes-of-health , European-union-eu-clinical-trial-application , Drug-administration , Fast-track , European-union , Clinical-trial-application , Accelerated-approval , Priority-review , Lupus-nephritis